Electronic fetal heart rate monitoring: early neonatal outcomes associated with normal rate, fetal stress, and fetal distress

Article Abstract:

A classification system for ranking electronic fetal heart rates as normal, fetal stress, or fetal distress can identify fetuses at risk of a poor outcome. In a study of 898 fetuses, 29% had tracings classified as fetal stress and 1% had tracings classified as fetal distress.

Diagnosis, Fetal distress, Fetal heart rate monitoring, Electronic fetal monitoring

---

A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns

Article Abstract:

Fetal pulse oximetry may reduce the rate of cesarean delivery in fetuses with abnormal heart rate patterns, according to a study of 1,010 women. Fetal pulse oximetry involves placing a catheter with an oxygen sensor at the tip inside the vagina. The sensor can measure oxygen levels through the skin on the baby's scalp.

Fetal monitoring, Oximetry

---

Dyatocia in nulliparous patients monitored with fetal pulse oximetry

Article Abstract:

Significantly nonreassuring fetal heart rate patterns predict cesarean delivery for dystocia among nulliparous patients with normally oxygenated fetuses in a setting of a standardized labor management protocol confirming the observations in the randomized controlled trial of fetal pulse oximetry in the United States.

Research and Development in the Physical, Engineering, and Life Sciences, Research and Testing Services, Gynecological R&D, Influence, Cesarean section, Fetal heart rate, Gynecological research

Similar abstracts:

• Abstracts: Multicenter, randomized, controlled trial of delayed pushing for nulliparous women in the second stage of labor with continuous epidural analgesia
• Abstracts: Functional and molecular characterization of nitric oxide synthase in the endometrium and myometrium of pregnant sheep during the last third of gestation
• Abstracts: The effect of fecal occult-blood screening on the incidence of colorectal cancer. Reducing mortality from colorectal cancer by screening for fecal occult blood
• Abstracts: Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. Telbivudine versus lamivudine in patients with chronic hepatitis B
• Abstracts: Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.